Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Zhenchong Xiong"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Large-scale genomic alterations, especially CD274/PD-L1 gene amplification, have great impact on anti-PD-1 efficacy on cancers such as Hodgkin’s lymphoma. However, the prevalence of PD-L1 genetic alterations in colorectal cancer
Externí odkaz:
https://doaj.org/article/08c86481516a442887f83f36db04d18b
Autor:
Jikun Feng, Jiarong Yi, Xiazi Zouxu, Jianxia Li, Zhenchong Xiong, Xinjian Huang, Wenjing Zhong, Weiling Huang, Feng Ye, Xi Wang
Publikováno v:
Cancer Medicine, Vol 11, Iss 15, Pp 2923-2933 (2022)
Abstract Background Host immunity plays an important role in tumor development and treatment. Tumor‐infiltrating lymphocytes (TILs) have been proven to predict the efficacy of neoadjuvant therapy (NAT) in breast cancer (BC) patients, but their appl
Externí odkaz:
https://doaj.org/article/9c2ab08385634c608eb630fc7891051c
Autor:
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 12, Pp n/a-n/a (2022)
Abstract Background Although chemotherapy, the most widely used systemic treatment in triple‐negative breast cancer (TNBC), markedly improved the patients’ outcome, chemoresistance always occurs. This study purposed to explore new therapeutic str
Externí odkaz:
https://doaj.org/article/82cfa577b3b24e0d8769fd43a6ae0878
Autor:
Zhenchong Xiong, Weiling Huang, Wenjing Zhong, Jianchang Fu, Jikun Feng, Xi Wang, Feihai Ling
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Purpose: The hypoxic tumor microenvironment was reported to be involved in different tumorigenesis mechanisms of breast cancer (BC). We aimed to establish a hypoxia-related gene signature to identify a new BC subtype through the clustering analysis a
Externí odkaz:
https://doaj.org/article/42f42ed4d7894c4691d239bbe2305483
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Obesity has been reported to be a risk factor for breast cancer, but how obesity affects breast cancer (BC) remains unclear. Although body mass index (BMI) is the most commonly used reference for obesity, it is insufficient to evaluate the obesity-re
Externí odkaz:
https://doaj.org/article/0e52d5c95cb140c28ec1a6f0e3bc40ca
Autor:
Zhenchong Xiong, Lin Yang, Juan Ao, Jiarong Yi, Xiazi Zouxu, Wenjing Zhong, Jikun Feng, Weiling Huang, Xi Wang, Zeyu Shuang
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
Breast cancer (BC) is the most diagnosed cancer and the leading cause of cancer-related deaths in women. The purpose of this study was to develop a prognostic model based on BC-related DNA methylation pattern. A total of 361 BC incidence-related prob
Externí odkaz:
https://doaj.org/article/1937cdafcd7b41fd960c2db09e70a342
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-12 (2019)
Abstract Background In the post-Z0011 trial era, the need to perform surgical axillary staging for early-stage breast cancer patients, who are treated with breast-conserving therapy (BCT), is being questioned. We conducted a retrospective cohort stud
Externí odkaz:
https://doaj.org/article/dc430fb8015a4f0d9464fd6caaa5401b
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Resection of the primary tumor is recommended for symptom relief in de novo stage IV breast cancer. We explored whether local surgery could provide a survival benefit in these patients and attempted to characterize the population
Externí odkaz:
https://doaj.org/article/daeccdfa037246f6969d35d8d07424b1
Autor:
Lin Yang, Zhenchong Xiong, Qian Kun Xie, Wenzhuo He, Shousheng Liu, Pengfei Kong, Chang Jiang, Xiaojun Xia, Liangping Xia
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Initial primary colorectal cancer (IPCRC) has a high risk of developing into second primary colorectal cancer (SPCRC). Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) have different characteristics and are conside
Externí odkaz:
https://doaj.org/article/8accd5044e6642cfa6ea9a290943ae5e
Autor:
Zhenchong Xiong, Liping Ye, He Zhenyu, Fengyan Li, Yahui Xiong, Chuyong Lin, Xianqiu Wu, Guangzheng Deng, Wei Shi, Libing Song, Zhongyu Yuan, Xi Wang
Publikováno v:
Molecular Oncology, Vol 12, Iss 6, Pp 896-912 (2018)
Triple‐negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor, and the HER2 receptor; it is highly proliferative and becomes the deadliest forms of breast cancer. Effective prognostic methods and therapeutic
Externí odkaz:
https://doaj.org/article/ae7225bcfa8d49139aaf35117b0d8f1a